Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2026 17:01 ET | Source: Keeps

Keeps Hair Growth Product Claims Evaluated: Topical & Oral RX Hair Loss Prescription Treatment with Finasteride, Dutasteride & Minoxidil

Keeps presents finasteride, dutasteride & minoxidil prescription hair loss plans for men via telehealth clinician assessment — 2026 platform overview.
April 17, 2026 17:00 ET | Source: HYTN Innovations Inc.

HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in...
April 17, 2026 17:00 ET | Source: LGI Homes, Inc.

LGI Homes Expands in the Salt Lake City Market with Grand Opening of Desert Edge

LGI Homes proudly announces the grand opening of Desert Edge, further expanding the company’s presence into Tooele County and the Salt Lake City market.
April 17, 2026 16:42 ET | Source: Coalition of Asia Pacific Tobacco Harm Reduction Advocates

CAPHRA: Making NRTs Harder to Get is Public Health Madness

CAPHRA believes that India risks making it harder for people who smoke to quit if they initiate a restriction on nicotine gums and lozenges.
April 17, 2026 16:10 ET | Source: Zacatecas Silver Corp.

Zacatecas Silver Announces Investor Relations Engagement

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (TSXV: ZAC; OTC: ZCTSF; Frankfurt: 7TV) (“Zacatecas” or the “Company”) announces it has entered into an...
April 17, 2026 16:05 ET | Source: ORIC Pharmaceuticals

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...
April 17, 2026 16:01 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

SAN DIEGO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a...
April 17, 2026 16:01 ET | Source: Adagene Inc.

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

Triple combination of muzastotug + atezolizumab + bevacizumab resulted in much higher overall response rates (ORR) compared to the atezolizumab + bevacizumab control arm (66.7% vs. 32.5%, respectively...
April 17, 2026 15:48 ET | Source: Nutraville

Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints

Nutraville's Genesis Revival pineal gland support ingredients, safety considerations, and consumer purchasing questions outlined in this 2026 overview.
April 17, 2026 15:35 ET | Source: Introspect Technology

Introspect Technology Adds New ATE-on-Bench Solution for LPDDR6, DDR6, and HBM Interfaces

M5504 is an ultra-compact ATE-on-bench system enabling high-speed LPDDR6, DDR6, and HBM memory interface validation and characterization.